Editor Profile
Dr. Babak Abdolkarimi, M.D.
Associate Professor
Present
Tehran University of Medical Sciences – Hakim Children’s Hospital
Tehran
Islamic Republic of Iran
Dr. Babak Abdolkarimi, MD, MSc, Fellowship
Associate Professor of Pediatric Hematology-Oncology
Tehran University of Medical Sciences – Hakim Children’s Hospital
Contact Information
• Email: B.abdolkarimi@yahoo.com
• Phone: +98 918 360 5274
• Address: Hakim Children’s Hospital, Tehran, Iran
Professional Summary
Associate Professor of Pediatric Hematology-Oncology at Tehran University of Medical Sciences, practicing at Hakim Children’s Hospital, with extensive clinical, academic, and leadership experience. Founder of several pioneering initiatives in pediatric oncology in Iran, including metronomic chemotherapy, IPINOC (Iran Pediatric Independent Neuro-Oncology Consortium), and innovative training programs for oncology nursing and pediatric hematology-oncology fellowships. Experienced in interventional pediatric oncology with expertise in intra-arterial chemotherapy and chemoembolization for abdominal, pelvic, and intracranial tumors in children. Active contributor to medical education reform and curriculum design at national level.
Education & Training
• Fellowship in Clinical Informatics
• MSc in Medical Education
• Fellowship in Pediatric Hematology-Oncology, Shiraz University of Medical Sciences
• Pediatric Residency, [Insert University], Iran
• Doctor of Medicine (MD), [Insert University], Iran
Academic Appointments
• Associate Professor, Department of Pediatrics, Tehran University of Medical Sciences
• Practicing Pediatric Hematologist-Oncologist at Hakim Children’s Hospital, Tehran
• Former Vice-Dean of Education, School of Medicine, Tehran
• Former Vice-Dean of Education, School of Medicine, Tehran University of Medical Sciences
• Faculty Member, Department of Pediatric Hematology-Oncology
- Metronomic chemotherapy in pediatric oncology
- Pediatric neuro-oncology and interventional chemotherapy
- Medical education and curriculum development
- Hematological malignancies and rare pediatric tumors
